BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 33099572)

  • 1. N
    Wang Q; Guo X; Li L; Gao Z; Su X; Ji M; Liu J
    Cell Death Dis; 2020 Oct; 11(10):911. PubMed ID: 33099572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N
    Yu H; Zhao K; Zeng H; Li Z; Chen K; Zhang Z; Li E; Wu Z
    Biomed Pharmacother; 2021 Jan; 133():111075. PubMed ID: 33378974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic m
    Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
    Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
    Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
    Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m
    Zhao W; Cui Y; Liu L; Ma X; Qi X; Wang Y; Liu Z; Ma S; Liu J; Wu J
    Mol Ther Nucleic Acids; 2020 Jun; 20():1-12. PubMed ID: 32145676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N
    Li F; Yi Y; Miao Y; Long W; Long T; Chen S; Cheng W; Zou C; Zheng Y; Wu X; Ding J; Zhu K; Chen D; Xu Q; Wang J; Liu Q; Zhi F; Ren J; Cao Q; Zhao W
    Cancer Res; 2019 Nov; 79(22):5785-5798. PubMed ID: 31530567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N
    Wang W; Shao F; Yang X; Wang J; Zhu R; Yang Y; Zhao G; Guo D; Sun Y; Wang J; Xue Q; Gao S; Gao Y; He J; Lu Z
    Nat Commun; 2021 Jun; 12(1):3803. PubMed ID: 34155197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N
    Li Y; He L; Wang Y; Tan Y; Zhang F
    Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Xue L; Li J; Lin Y; Liu D; Yang Q; Jian J; Peng J
    J Cell Physiol; 2021 Apr; 236(4):2649-2658. PubMed ID: 32892348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA m
    Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
    EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3-mediated m
    Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
    J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-dependent N
    Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
    Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
    Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
    Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3/YTHDF1 m
    Zhi D; Zhou K; Liu S; Yu W; Dong M; Yan C
    Pathol Res Pract; 2024 Jan; 253():155047. PubMed ID: 38154356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m
    He Y; Wang W; Xu X; Yang B; Yu X; Wu Y; Wang J
    Bone; 2022 Jan; 154():116182. PubMed ID: 34530171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.